Overview
Frederik Damm practices in Hannover, Germany. Mr. Damm is rated as an Advanced expert by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Primary Mediastinal B-Cell Lymphoma (PMBCL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.
His clinical research consists of co-authoring 81 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Chronic Lymphocytic Leukemia (CLL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Mr. Damm isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Damm isDistinguished. Learn about Leukemia.
- Advanced
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Myelodysplastic Syndrome (MDS)
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Experienced
- Acute Myelomonocytic LeukemiaMr. Damm isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Soft Tissue SarcomaMr. Damm isExperienced. Learn about Adult Soft Tissue Sarcoma.
- B-Cell LymphomaMr. Damm isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Damm isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaMr. Damm isExperienced. Learn about Burkitt Lymphoma.
- Chronic Myelomonocytic Leukemia (CMML)